Sutro Biopharma, Inc. (STRO)
15.52
+0.92
(+6.30%)
USD |
NASDAQ |
Feb 06, 16:00
15.55
+0.03
(+0.19%)
After-Hours: 20:00
Sutro Biopharma EPS Diluted (Quarterly) : -6.699 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.86M |
| Revenue (Quarterly) | 9.693M |
| Total Expenses (Quarterly) | 66.55M |
| Enterprise Value | 192.17M |
| Gross Profit Margin (Quarterly) | 80.40% |
| Profit Margin (Quarterly) | -586.6% |
| Earnings Yield | -114.4% |
| Normalized Earnings Yield | -98.33 |